OX40 agonist therapy enhances CD8 infiltration and decreases immune suppression in the tumor. (Q51963656)
Jump to navigation
Jump to search
scientific article published in July 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | OX40 agonist therapy enhances CD8 infiltration and decreases immune suppression in the tumor. |
scientific article published in July 2008 |
Statements
1 reference
OX40 agonist therapy enhances CD8 infiltration and decreases immune suppression in the tumor. (English)
1 reference
1 reference
Carl E Ruby
1 reference
Birat Dhungel
1 reference
Alexis Brown
1 reference
Andrew D Weinberg
1 reference
1 July 2008
1 reference
1 reference
68
1 reference
13
1 reference
5206-5215
1 reference
Identifiers
1 reference